Alterity Therapeutics (ATHE) Current Assets (2009 - 2025)

Alterity Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $37.3 million for Q4 2025.

• On a quarterly basis, Current Assets rose 446.92% year-over-year to $37.3 million in Q4 2025; TTM through Dec 2025 was $37.3 million, a 446.92% increase from a year earlier, with the FY2025 full-year figure at $29.4 million, up 134.16% from the prior year.
• Current Assets rose to $37.3 million in Q4 2025 per ATHE's latest filing, from $29.4 million in the prior quarter.
• Across five years, Current Assets topped out at $37.3 million in Q4 2025 and bottomed at $270487.7 in Q2 2023.
• The 5-year median for Current Assets is $23.8 million (2021), against an average of $21.0 million.
• Across the five-year window, Current Assets slumped 99.08% in 2023 and jumped 4538.2% in 2024, its largest moves.
• Year by year, Current Assets stood at $32.7 million in 2021, then sank by 33.24% to $21.8 million in 2022, then tumbled by 34.38% to $14.3 million in 2023, then plunged by 52.35% to $6.8 million in 2024, then jumped by 446.92% to $37.3 million in 2025.
• Per Business Quant, the three latest ATHE Current Assets figures stand at $37.3 million (Q4 2025), $29.4 million (Q2 2025), and $6.8 million (Q4 2024).